Furthermore, a positive correlation was found between α-synuclein, a protein involved in the regulation of dopamine release and associated with neurodegenerative disease, and CXCL12 in the postmortem brain tissue of PD patients (Li et al., 2019; Nanki & Lipsky, 2000). This evidence concerns the gene CXCL12 and Parkinson disease.